Compass Therapeutics's total assets for Q1 2026 were $205.17M, a decrease of -6.57% from the previous quarter. CMPX total liabilities were $18.70M for the fiscal quarter, a -17.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.